Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash flows from operating activities:
Net loss	$ (49,851,140)	$ (1,137,144)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization	626,077	59,192
Amortization of debt issuance costs	2,043,458
Loss on issuance of warrants	43,541,211
Provision for bad debts	608,356	46,705
Gain on sale	5,897
Changes in assets and liabilities:
Accounts receivable	(1,482,070)	(149,484)
Inventories	(3,323,971)	28,029
Prepaid expenses and other current assets	749,086	(785,899)
Accounts payable	(159,375)	1,458
Accrued expenses and other current liabilities	2,305,191	385,232
Net cash provided by (used in) operating activities	(4,937,282)	(1,551,911)
Cash flows from investing activities:
Purchases of property and equipment	(36,307)	(6,595)
Purchase of developed technology	(77,491)
Proceeds from sale of property and equipment	181,000
Net cash provided by investing activities	67,202	(6,595)
Cash flows from financing activities:
Net proceeds from issuance of common stock	14,598
Net borrowings under convertible notes	3,150,000
Due to Former Parent		1,687,891
Fees paid for financing costs	(664,389)
Repayments under lines of credit		(27,644)
Repayments under convertible notes payable – related parties	(116,300)
Repayments under notes payable
Net cash provided by (used in) financing activities	2,383,909	1,660,247
Net increase (decrease) in cash and cash equivalents	(2,486,171)	101,741
Cash and cash equivalents, beginning of the year	5,580,431	911,194
Cash and cash equivalents, end of the period	3,094,260	1,012,935
Supplemental disclosure of cash flow information:
Cash paid for interest		46,492
Cash paid for income taxes
Issuance of warrants to noteholders and placement agent	4,335,611
Original issue discount	555,000
Convertible shares under notes payable	$ 7,743,333